With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

The surgical robotics maker posts better-than-expected quarterly earnings as it begins rollout of cardiac procedures.

Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing ...

This robotic surgical systems pioneer is dealing with a few issues, but its opportunities remain promising.

If you are wondering whether Intuitive Surgical at around US$525 a share still makes sense for your portfolio, the key ...

Intuitive Surgical capped off the recovery in its shares with a strong Q4 2025 earnings release, lending support to the stock ...

Investing.com -- TD Cowen initiated coverage of Intuitive Surgical with a Buy rating and a $660 price target, saying the launch of the da Vinci 5 system is driving a long-tailed product cycle that can ...

Medical technology company Intuitive Surgical (NASDAQ:ISRG) announced better-than-expected revenue in Q4 CY2025, with sales ...

Intuitive Surgical has received FDA clearance for cardiac procedures using the da Vinci 5 surgical robot, according to a Jan. 26 report from Mass Device. The new cardiac clearances cover mitral valve ...

MemorialCare Long Beach Medical Center is a regional leader in robotic surgery with the new da Vinci 5. See how this tech ...

Intuitive Surgical Inc (NASDAQ:ISRG) reports financial results for the fourth quarter on Thursday. Here's a rundown of the ...

Intuitive Surgical (NASDAQ: ISRG) reports in-line Q4 results, sets measured guidance for 2026, with an 18% revenue growth and ...